A powerful investment alliance of Aztiq and Innobic acquires Alvogen’s shares in Lotus and Adalvo in a US$475m deal

Newly issued share equity in Alvogen US acquired by Aztiq Pharma Partners

Alvogen and sister company Alvotech donate 100 thousand US dollars to UNICEF in combat against COVID-19

One of the guiding principles at Alvogen has always been to give back to the communities in which we serve, but Dr. Chandrashekhar Nimkar has clearly taken this to a whole new level, as a philanthropist with both a global and local reach.

Frontline warrior against COVID-19

Alvogen and Alvotech launch new B2B business brand

Alvogen’s subsidiary in Asia, Lotus Pharmaceuticals announces new global partnerships to drive growth

Alvogen completes sale of its Central and Eastern European business to Zentiva Group

Alvogen submits European application for generic Pazopanib

Delivering on our promise during the Coronavirus Pandemic

Kick-Off Meeting in Mexico

Alvotech and JAMP Pharma enter into an exclusive partnership for the commercialization of key biosimilars in Canada

Alvogen and Yas Holding announce license and distribution agreement to commercialize generics portfolio in MENA Region

Alvogen at CPhI 2019

Alvogen announces divestment of its Central and Eastern European Business to Zentiva Group

Alvogen announces exclusive commercialization agreements in South Korea, Israel and Canada for Teriparatide (PF708)

Alvogen is warming up for CPhI 2019 in Frankfurt

Alvogen receives approval of Qsymia® in the Republic of Korea

Alvogen announces distribution agreement with Covis Pharma for a leading asthma medicine

Alvogen and Lotus announce first to launch generic version of Navelbine® softgel capsule in Europe

Download center for company logos and images

Elisabet Hjaltadottir

Media contact

Latest News